Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
Huttner, Angela, Dr, Hatz, Christoph, Prof, van den Dobbelsteen, Germie, PhD, Abbanat, Darren, PhD, Hornacek, Alena, MSc, Frölich, Rahel, BSc, Dreyer, Anita M, PhD, Martin, Patricia, PhD, Davies, Todd, PhD, Fae, Kellen, PhD, van den Nieuwenhof, Ingrid, PhD, Thoelen, Stefan, MD, de Vallière, Serge, MD, Kuhn, Anette, Prof, Bernasconi, Enos, MD, Viereck, Volker, Prof, Kavvadias, Tilemachos, MD, Kling, Kerstin, MD, Ryu, Gloria, MD, Hülder, Tanja, MD, Gröger, Sabine, MD, Scheiner, David, MD, Alaimo, Cristina, PhD, Harbarth, Stephan, MD, Poolman, Jan, PhD, Fonck, Veronica Gambillara, PhD
Published in The Lancet infectious diseases (01.05.2017)
Published in The Lancet infectious diseases (01.05.2017)
Get full text
Journal Article